Skip to content

Clinical trials

Phase 3 Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 3 Clear all

590 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200112
200212
200318
200435
200548
200651
200745
200845
200917
201021
201129
201222
201316
201419
201510
201611
201713
201812
201916
202012
202113
20229
202311
202411
202513
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed478
Unknown status35
Terminated30
Withdrawn18
Recruiting11
Active, not recruiting7
Not yet recruiting7
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis79
Boehringer Ingelheim43
Takeda23
National Heart, Lung, and Blood Institute (NHLBI)20
Novartis Pharmaceuticals20
AstraZeneca16
Hanmi Pharmaceutical Company Limited16
Organon and Co15
Alcon Research9
Bayer9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension590
Cardiovascular Diseases58
Essential Hypertension48
Diabetes Mellitus35
Diabetes Mellitus, Type 229
Vascular Diseases29
Heart Diseases28
Dyslipidemias23
Obesity23
Hyperlipidemias22

Trials

Showing 76 to 100 of 590. Each trial links to its page on Pharma Observatory.

490 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.